- About BME
- Academics Home
- Combined Degrees
- Student Resources
- Industry Home
- Partner Benefits
- Student Design Projects
- Guest Lectures
- BME Interns
- Research Collaborations
- Tech Licensing
- Industry News
- "Women's Radio Network Open Forum" To Feature AxoGen, Inc.
- 3rd Annual Pruitt Research Day
- AxoGen, Inc. Announces Clearance from FDA to Proceed with New Multicenter Comparative Study for Avance® Nerve Graft
- AxoGen, Inc. Announces Completion of a Pilot Clinical Study Assessing Cavernous Nerve Reconstruction with Avance® Nerve Graft
- BioD LLC Makes $1 Million Gift Commitment to UF BME
- BioD Receives U.S. Patent for Unique Placental Tissue Technology
- Dr. Peter McFetridge awarded the Tim Brahm Professorship
- Event Celebrates BioD’s $1 Million Gift to BME
- New Industry Partner: Sigma Aldrich Corporation
- RTI Surgical™ Announces Agreement With Novation
- Record BME Industry Partner Participation at the 4th Annual Pruitt Research Day
- SPECIAL EVENT: “Geraldo Rivera Show” to Feature AxoGen, Inc.
- Stryker Provides Guest Lecture to BME Students
- Contact Us
UF BME postdoctoral associate assumes a faculty position at the University of Nebraska-Lincoln
January 31, 2017
Congratulations to Dr. Rebecca Wachs, a former postdoctoral associate with Pruitt Family Professor and Department Chair, Dr. Christine E. Schmidt, who has joined the University of Nebraska-Lincoln as an assistant professor in biological systems engineering.
Wachs earned her Ph.D. in biomedical engineering from Rensselaer Polytechnic Institute on the mechanisms of low back pain, and her B.S. in mechanical engineering from Worcester Polytechnic Institute. She worked for a medical device company, RTI Surgical, Inc., as a senior engineer in research and development. For the past two years, Wachs has pursued postdoctoral studies at the University of Florida Biomedical Engineering department in the Schmidt Lab. Wachs’ research vision is to use her diverse skills in orthopedics, neural engineering, and clinical translation to develop novel interventions for the treatment of low back pain. She proposes to target this pain with three major arms of research: engineered biomaterials to prevent and reverse nerve growth, targeted delivery of antioxidants to modulate inflammation, and development of in vitro test beds to mimic disease progression.
Congratulations, Dr. Wachs!